Correlation Between Carmell Therapeutics and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Carmell Therapeutics and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Carmell Therapeutics and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Carmell Therapeutics and ZyVersa Therapeutics, you can compare the effects of market volatilities on Carmell Therapeutics and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Carmell Therapeutics with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Carmell Therapeutics and ZyVersa Therapeutics.
Diversification Opportunities for Carmell Therapeutics and ZyVersa Therapeutics
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Carmell and ZyVersa is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Carmell Therapeutics and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Carmell Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Carmell Therapeutics are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Carmell Therapeutics i.e., Carmell Therapeutics and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Carmell Therapeutics and ZyVersa Therapeutics
Assuming the 90 days horizon Carmell Therapeutics is expected to generate 2.18 times more return on investment than ZyVersa Therapeutics. However, Carmell Therapeutics is 2.18 times more volatile than ZyVersa Therapeutics. It trades about 0.02 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 41.00 in Carmell Therapeutics on August 31, 2024 and sell it today you would lose (35.00) from holding Carmell Therapeutics or give up 85.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 37.43% |
| Values | Daily Returns |
Carmell Therapeutics vs. ZyVersa Therapeutics
Performance |
| Timeline |
| Carmell Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Insignificant
| ZyVersa Therapeutics |
Carmell Therapeutics and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Carmell Therapeutics and ZyVersa Therapeutics
The main advantage of trading using opposite Carmell Therapeutics and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Carmell Therapeutics position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| Carmell Therapeutics vs. ZyVersa Therapeutics | Carmell Therapeutics vs. Sonnet Biotherapeutics Holdings | Carmell Therapeutics vs. Revelation Biosciences | Carmell Therapeutics vs. Quoin Pharmaceuticals Ltd |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |